Drugs & TargetsFree Alimta + Keytruda and platinum chemo for NSCLC gets FDA label expansion February 01, 2019Vol.45 No.05
Drugs & TargetsFree Trovagene and PoC Capital agree to fund clinical development of onvansertib in metastatic colorectal cancer February 01, 2019Vol.45 No.05
Drugs & TargetsFree European Commission authorizes Rubraca tablets in ovarian cancer January 25, 2019Vol.45 No.04
Drugs & TargetsFree Bristol-Myers Squibb withdraws U.S. application for Opdivo + Yervoy in first-line lung cancer January 25, 2019Vol.45 No.04
Drugs & TargetsFree FDA finalizes policy on labeling for accelerated approval drugs January 25, 2019Vol.45 No.04
Drugs & TargetsFree FDA grants Illumina’s TruSight Assay Breakthrough Device designation January 25, 2019Vol.45 No.04
Drugs & TargetsFree Genmab initiates of FDA submission for expansion of daratumumab in multiple myeloma January 25, 2019Vol.45 No.04
Drugs & Targets FDA approves Cabometyx for previously treated hepatocellular carcinoma January 18, 2019Vol.45 No.03
Drugs & Targets European Commission approves Opdivo + low-dose Yervoy in RCC January 18, 2019Vol.45 No.03
